Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced it has received an ...

Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...

The Centers for Medicare and Medicaid Services aims to have all Medicare beneficiaries in a value-based arrangement by 2030. But achieving that will be a difficult undertaking, with just 12% of ...

Spectral Labs, a crypto development firm focused on artificial intelligence, wants to make it easier for non-programmers to build on blockchains. On Tuesday the company will launch Syntax, an AI app ...

Percutaneous coronary intervention (PCI) involving drug-eluting stents is increasingly used to treat complex coronary artery disease, although coronary-artery bypass grafting (CABG) has been the ...